New research group accredited: UEM
A new consolidated research group is benn registered in the IDIAPJGol, the UEM (Unitat d’Estudis del Medicament)
The UEM research group is a multidisciplinar group of 8 members with a large career since 2012. The main investigations include independent clinical trials in the primary care ambit and pharmacoepidemiology observing with de SIDIAP database, doing studies with public and private financiation, in national and international field in colaboration with other research groups.
The UEM is in the SCReN platform (Spanish Clinical Research Network) since the 2013, a structure that supports the independent investigation like the multicentrical, and also had been part from the old CAIBER (Plataforma española de ensayos clínicos).
In the UEM wue coordinate the Oficina Técnica de Farmacoepidemiología (OTF), created on 2017 because of an agreement between the IDIAPJGol, the ICS and the CatSalut, to support the Programa d’Harmonització Farmacoterapeutica of the CatSalut by pharmacoepidemiologyc studies.
The UEM is part of a investigation group in the field of the use of pharmacs during the pregnancy and lacancy admited by the European Medicines Agency (EMA) on 2017, leaded by the epidemiologyc department of the Aarhus University, Denmark (Procurement procedure no. EMA/2017/09/PE – Efficacy and safety studies on medicines. Lot 4: Pharmacoepidemiology research – association studies, including pregnancy and breastfeeding research).
It's also part of the SIGMA Consortium platform since 2019, a concortium that gives cientific evidence on pharmacoepidemilogy with a european health database net.
Group investigationso:
- Pharmac uses on special situations/population: pediatriac pregnancy, lactancy, mental health.
- Study of the uses pattern related to the pharmac adhesion.
- Study of the clinic consequencies of the no adhesion to pharmacs.
- Promote the realization of clinical trials and other pragmatic research studies on the common clinic practise.
